Volume 596 Issue 7871, 12 August 2021
Article | 10 June 2021
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
Samples of serum from individuals immunized with the BNT162b2 vaccine show neutralization activity against engineered SARS-CoV-2s bearing the spike mutations from B.1.617 and other variants.
Jianying Liu, Yang Liu, Pei-Yong Shi